Stock Update: Medtronic Inc (NYSE:MDT) – Medtronic Initiates Pivotal Studies of Resolute Onyx(TM) Drug-Eluting Stent in United States

[Thomson Reuters ONE] – Next-Generation Device with CoreWire Technology to be Studied in Wide Spectrum of Patients, Including the Smallest Coronary Arteries DUBLIN – March 12, 2015 – Medtronic plc (NYSE: MDT) today . . . → Read More: Stock Update: Medtronic Inc (NYSE:MDT) – Medtronic Initiates Pivotal Studies of Resolute Onyx(TM) Drug-Eluting Stent in United States Similar Articles: Company Update (NYSE:MDT): Medtronic EVP & CFO Gary Ellis to Speak at Barclays Healthcare Conference Company Update: Medtronic Inc (NYSE:MDT) – Medtronic EVP & President Michael J. Coyle to Speak at Cowen Healthcare Conference Company Update (NYSE:MDT): Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2015